{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:43:21Z","timestamp":1761864201262,"version":"3.37.3"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T00:00:00Z","timestamp":1604880000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T00:00:00Z","timestamp":1604880000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Cardiovasc Imaging"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s10554-020-02094-y","type":"journal-article","created":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T09:08:56Z","timestamp":1604912936000},"page":"1131-1141","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Difference of vascular healing between bioabsorbable-polymer and durable-polymer new generation drug-eluting stents: an optical coherence tomographic analysis"],"prefix":"10.1007","volume":"37","author":[{"given":"Yutaka","family":"Matsuhiro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryu","family":"Shutta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akito","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naotaka","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuharu","family":"Matsunaga-Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masamichi","family":"Yano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyuki","family":"Egami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Sakata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0309-7023","authenticated-orcid":false,"given":"Masami","family":"Nishino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Tanouchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,9]]},"reference":[{"issue":"14","key":"2094_CR1","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1056\/NEJMoa035071","volume":"349","author":"JW Moses","year":"2003","unstructured":"Moses JW, Leon MB, Popma JJ et al (2003) Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349(14):1315\u20131323","journal-title":"N Engl J Med"},{"issue":"18","key":"2094_CR2","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1161\/CIRCULATIONAHA.106.658237","volume":"115","author":"S Cook","year":"2007","unstructured":"Cook S, Wenaweser P, Togni M et al (2007) Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation 115(18):2426\u20132434","journal-title":"Circulation"},{"issue":"3","key":"2094_CR3","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1056\/NEJMra1210816","volume":"368","author":"GG Stefanini","year":"2013","unstructured":"Stefanini GG, Holmes DR Jr (2013) Drug-eluting coronary-artery stents. N Engl J Med 368(3):254\u2013265","journal-title":"N Engl J Med"},{"issue":"18","key":"2094_CR4","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1161\/CIRCULATIONAHA.107.693739","volume":"115","author":"AV Finn","year":"2007","unstructured":"Finn AV, Joner M, Nakazawa G et al (2007) Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation 115(18):2435\u20132441","journal-title":"Circulation"},{"issue":"4","key":"2094_CR5","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jcin.2009.01.004","volume":"2","author":"AV Finn","year":"2009","unstructured":"Finn AV, Nakazawa G, Kolodgie FD et al (2009) Temporal course of neointimal formation after drug-eluting stent placement: is our understanding of restenosis changing? JACC Cardiovasc Interv 2(4):300\u2013302","journal-title":"JACC Cardiovasc Interv"},{"issue":"1","key":"2094_CR6","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jacc.2006.03.042","volume":"48","author":"M Joner","year":"2006","unstructured":"Joner M, Finn AV, Farb A et al (2006) Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 48(1):193\u2013202","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"2094_CR7","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1161\/01.CIR.0000116202.41966.D4","volume":"109","author":"R Virmani","year":"2004","unstructured":"Virmani R, Guagliumi G, Farb A et al (2004) Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 109(6):701\u2013705","journal-title":"Circulation"},{"issue":"12","key":"2094_CR8","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/j.jcin.2013.06.015","volume":"6","author":"T Tada","year":"2013","unstructured":"Tada T, Byrne RA, Simunovic I et al (2013) Risk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and second-generation drug-eluting stents: results from a registry of 18,334 patients. JACC Cardiovasc interv 6(12):1267\u20131274","journal-title":"JACC Cardiovasc interv"},{"issue":"9","key":"2094_CR9","doi-asserted-by":"publisher","first-page":"e003785","DOI":"10.1161\/CIRCINTERVENTIONS.116.003785","volume":"9","author":"D Nakamura","year":"2016","unstructured":"Nakamura D, Attizzani GF, Toma C et al (2016) Failure mechanisms and neoatherosclerosis patterns in very late drug-eluting and bare-metal stent thrombosis. Circ Cardiovasc Interv 9(9):e003785","journal-title":"Circ Cardiovasc Interv"},{"issue":"7","key":"2094_CR10","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1161\/CIRCULATIONAHA.115.019071","volume":"133","author":"M Taniwaki","year":"2016","unstructured":"Taniwaki M, Radu MD, Zaugg S et al (2016) Mechanisms of very late drug-eluting stent thrombosis assessed by optical coherence tomography. Circulation 133(7):650\u2013660","journal-title":"Circulation"},{"issue":"26","key":"2094_CR11","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1093\/eurheartj\/ehy273","volume":"39","author":"G Guagliumi","year":"2018","unstructured":"Guagliumi G, Shimamura K, Sirbu V et al (2018) Temporal course of vascular healing and neoatherosclerosis after implantation of durable- or biodegradable-polymer drug-eluting stents. Eur Heart J 39(26):2448\u20132456","journal-title":"Eur Heart J"},{"issue":"42","key":"2094_CR12","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.1093\/eurheartj\/ehx351","volume":"38","author":"T Kubo","year":"2017","unstructured":"Kubo T, Shinke T, Okamura T et al (2017) Optical frequency domain imaging vs. intravascular ultrasound in percutaneous coronary intervention (OPINION trial): one-year angiographic and clinical results. Eur Heart J 38(42):3139\u20133147","journal-title":"Eur Heart J"},{"issue":"4","key":"2094_CR13","doi-asserted-by":"publisher","first-page":"e002372","DOI":"10.1161\/CIRCINTERVENTIONS.114.002372","volume":"8","author":"DJ Kereiakes","year":"2015","unstructured":"Kereiakes DJ, Meredith IT, Windecker S et al (2015) Efficacy and safety of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stent: the EVOLVE II Randomized Trial. Circ Cardiovasc Interv 8(4):e002372","journal-title":"Circ Cardiovasc Interv"},{"issue":"30","key":"2094_CR14","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1093\/eurheartj\/ehu210","volume":"35","author":"S Saito","year":"2014","unstructured":"Saito S, Valdes-Chavarri M, Richardt G et al (2014) A randomized, prospective, intercontinental evaluation of a bioresorbable polymer sirolimus-eluting coronary stent system: the CENTURY II (clinical evaluation of new terumo drug-eluting coronary stent system in the treatment of patients with coronary artery disease) trial. Eur Heart J 35(30):2021\u20132031","journal-title":"Eur Heart J"},{"issue":"10205","key":"2094_CR15","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/S0140-6736(19)31877-X","volume":"394","author":"JF Iglesias","year":"2019","unstructured":"Iglesias JF, Muller O, Heg D et al (2019) Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial. Lancet 394(10205):1243\u20131253","journal-title":"Lancet"},{"issue":"10154","key":"2094_CR16","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/S0140-6736(18)32001-4","volume":"392","author":"C von Birgelen","year":"2018","unstructured":"von Birgelen C, Zocca P, Buiten RA et al (2018) Thin composite wire strut, durable polymer-coated (Resolute Onyx) versus ultrathin cobalt-chromium strut, bioresorbable polymer-coated (Orsiro) drug-eluting stents in allcomers with coronary artery disease (BIONYX): an international, single-blind, randomised non-inferiority trial. Lancet 392(10154):1235\u20131245","journal-title":"Lancet"},{"issue":"35","key":"2094_CR17","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.1093\/eurheartj\/ehy285","volume":"39","author":"L R\u00e4ber","year":"2018","unstructured":"R\u00e4ber L, Mintz GS, Koskinas KC et al (2018) Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions. Eur Heart J 39(35):3281\u20133300","journal-title":"Eur Heart J"},{"issue":"19","key":"2094_CR18","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1016\/j.jacc.2013.05.071","volume":"62","author":"H Jia","year":"2013","unstructured":"Jia H, Abtahian F, Aguirre AD et al (2013) In vivo diagnosis of plaque erosion and calcified nodule in patients with acute coronary syndrome by intravascular optical coherence tomography. J Am Coll Cardiol 62(19):1748\u20131758","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"2094_CR19","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1093\/ehjci\/jex334","volume":"19","author":"S Cassese","year":"2018","unstructured":"Cassese S, Xhepa E, Ndrepepa G et al (2018) Vascular response to percutaneous coronary intervention with biodegradable-polymer vs new-generation durable-polymer drug-eluting stents: a meta-analysis of optical coherence tomography imaging trials. Eur Heart J Cardiovasc Imaging 19(11):1294\u20131301","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"7","key":"2094_CR20","doi-asserted-by":"publisher","first-page":"e011817","DOI":"10.1161\/JAHA.118.011817","volume":"8","author":"E Im","year":"2019","unstructured":"Im E, Hong SJ, Ahn CM et al (2019) Long-Term Clinical Outcomes of Late Stent Malapposition Detected by Optical Coherence Tomography After Drug-Eluting Stent Implantation. Journal of the American Heart Association 8(7):e011817","journal-title":"Journal of the American Heart Association"},{"issue":"1","key":"2094_CR21","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1161\/CIRCINTERVENTIONS.113.000797","volume":"7","author":"E Im","year":"2014","unstructured":"Im E, Kim BK, Ko YG et al (2014) Incidences, predictors, and clinical outcomes of acute and late stent malapposition detected by optical coherence tomography after drug-eluting stent implantation. Circ Cardiovasc Interv 7(1):88\u201396","journal-title":"Circ Cardiovasc Interv"},{"issue":"8476","key":"2094_CR22","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","volume":"1","author":"JM Bland","year":"1986","unstructured":"Bland JM, Altman DG (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1(8476):307\u2013310","journal-title":"Lancet"},{"issue":"11","key":"2094_CR23","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1161\/CIRCULATIONAHA.107.762047","volume":"118","author":"G Nakazawa","year":"2008","unstructured":"Nakazawa G, Finn AV, Joner M et al (2008) Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study. Circulation 118(11):1138\u20131145","journal-title":"Circulation"},{"issue":"26","key":"2094_CR24","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1093\/eurheartj\/ehy338","volume":"39","author":"DJ Kereiakes","year":"2018","unstructured":"Kereiakes DJ (2018) Healing by design: in vivo insights following contemporary coronary stent deployment. Eur Heart J 39(26):2457\u20132459","journal-title":"Eur Heart J"},{"issue":"2","key":"2094_CR25","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/ehjci\/jew070","volume":"18","author":"M Iannaccone","year":"2017","unstructured":"Iannaccone M, D\u2019Ascenzo F, Templin C et al (2017) Optical coherence tomography evaluation of intermediate-term healing of different stent types: systemic review and meta-analysis. Eur Heart J Cardiovasc Imaging 18(2):159\u2013166","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"25","key":"2094_CR26","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.1161\/CIRCULATIONAHA.104.513952","volume":"111","author":"L Mauri","year":"2005","unstructured":"Mauri L, Orav EJ, Kuntz RE (2005) Late loss in lumen diameter and binary restenosis for drug-eluting stent comparison. Circulation 111(25):3435\u20133442","journal-title":"Circulation"},{"issue":"32","key":"2094_CR27","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1093\/eurheartj\/ehv205","volume":"36","author":"F Otsuka","year":"2015","unstructured":"Otsuka F, Byrne RA, Yahagi K et al (2015) Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment. Eur Heart J 36(32):2147\u20132159","journal-title":"Eur Heart J"},{"issue":"19","key":"2094_CR28","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1093\/eurheartj\/ehr182","volume":"32","author":"JL Guti\u00e9rrez-Chico","year":"2011","unstructured":"Guti\u00e9rrez-Chico JL, van Geuns RJ, Regar E et al (2011) Tissue coverage of a hydrophilic polymer-coated zotarolimus-eluting stent vs. a fluoropolymer-coated everolimus-eluting stent at 13-month follow-up: an optical coherence tomography substudy from the RESOLUTE All Comers trial. Eur Heart J 32(19):2454\u20132463","journal-title":"Eur Heart J"},{"issue":"5","key":"2094_CR29","doi-asserted-by":"publisher","first-page":"541","DOI":"10.4244\/EIJY14M08_06","volume":"11","author":"E Barbato","year":"2015","unstructured":"Barbato E, Salinger-Martinovic S, Sagic D et al (2015) A first-in-man clinical evaluation of Ultimaster, a new drug-eluting coronary stent system: CENTURY study. EuroIntervention 11(5):541\u2013548","journal-title":"EuroIntervention"},{"issue":"1","key":"2094_CR30","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jcmg.2017.06.021","volume":"11","author":"H Otake","year":"2018","unstructured":"Otake H, Kubo T, Takahashi H et al (2018) Optical frequency domain imaging versus intravascular ultrasound in percutaneous coronary intervention (OPINION trial): results from the OPINION imaging study. JACC Cardiovasc imaging 11(1):111\u2013123","journal-title":"JACC Cardiovasc imaging"},{"issue":"47","key":"2094_CR31","doi-asserted-by":"publisher","first-page":"3346","DOI":"10.1093\/eurheartj\/ehv367","volume":"36","author":"W Wijns","year":"2015","unstructured":"Wijns W, Shite J, Jones MR et al (2015) Optical coherence tomography imaging during percutaneous coronary intervention impacts physician decision-making: ILUMIEN I study. Eur Heart J 36(47):3346\u20133355","journal-title":"Eur Heart J"},{"issue":"10060","key":"2094_CR32","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1016\/S0140-6736(16)31922-5","volume":"388","author":"ZA Ali","year":"2016","unstructured":"Ali ZA, Maehara A, G\u00e9n\u00e9reux P et al (2016) Optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation (ILUMIEN III: OPTIMIZE PCI): a randomised controlled trial. Lancet 388(10060):2618\u20132628","journal-title":"Lancet"},{"issue":"5","key":"2094_CR33","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.jcin.2016.12.002","volume":"10","author":"G El-Hayek","year":"2017","unstructured":"El-Hayek G, Bangalore S, Casso Dominguez A et al (2017) Meta-analysis of randomized clinical trials comparing biodegradable polymer drug-eluting stent to second-generation durable polymer drug-eluting stents. JACC Cardiovasc interv 10(5):462\u2013473","journal-title":"JACC Cardiovasc interv"},{"issue":"10105","key":"2094_CR34","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1016\/S0140-6736(17)32249-3","volume":"390","author":"DE Kandzari","year":"2017","unstructured":"Kandzari DE, Mauri L, Koolen JJ et al (2017) Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial. Lancet 390(10105):1843\u20131852","journal-title":"Lancet"},{"issue":"11","key":"2094_CR35","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1016\/j.jcin.2020.02.019","volume":"13","author":"DE Kandzari","year":"2020","unstructured":"Kandzari DE, Koolen JJ, Doros G et al (2020) Ultrathin bioresorbable-polymer sirolimus-eluting stents versus thin durable-polymer everolimus-eluting stents for coronary revascularization: 3-year outcomes from the randomized BIOFLOW V trial. JACC Cardiovasc interv 13(11):1343\u20131353","journal-title":"JACC Cardiovasc interv"}],"container-title":["The International Journal of Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-020-02094-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10554-020-02094-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-020-02094-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T05:24:52Z","timestamp":1617773092000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10554-020-02094-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,9]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["2094"],"URL":"https:\/\/doi.org\/10.1007\/s10554-020-02094-y","relation":{},"ISSN":["1569-5794","1573-0743"],"issn-type":[{"type":"print","value":"1569-5794"},{"type":"electronic","value":"1573-0743"}],"subject":[],"published":{"date-parts":[[2020,11,9]]},"assertion":[{"value":"18 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional research committee and the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"Written informed consent was obtained from all participating patients and the protocol was approved by Osaka Rosai Hospital ethics committees.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}